Digital PCR And Real-time PCR Market - Industry Analysis, Market Size, Share, Trends, Application Analysis, Growth And Forecast 2021 - 2026

Report Code: HCR 14528 Report Format: PDF + Excel

Digital PCR and Real-time PCR Market Overview

The Digital PCR (dPCR) and Real-time PCR (qPCR) Market size was estimated at $4876 million in 2020, and is projected to grow at a CAGR of 9.2% during the forecast period 2021-2026. The polymerase chain reaction (PCR) is a technique used for amplifying a specific target DNA sequence exponentially, allowing for the isolation, sequencing, or cloning of a single sequence among many. PCR is routinely utilized for a wide variety of medical biotechnology applications including human genome mapping, genotyping, cloning, mutation detection, sequencing, microarrays, forensics, and paternity testing. The rising incidence of target infectious diseases and genetic disorders, technological advancements in PCR technologies, increased investments, funds, and grants, increased use of biomarker profiling for disease diagnostics, and the successful completion of the Human Genome Project all contribute to the market's growth. However, High instrument costs, particularly for dPCR, and the technical limits of PCR, on the other hand, are limiting market expansion during the forecast period 2021-2026.

Report Coverage

The report: “Digital PCR and Real-time PCR Market Forecast (2021-2026)”, by Industry ARC, covers an in-depth analysis of the following segments of the Digital PCR and Real-time PCR Market.
By Product and Service: Instruments, Reagents & Consumables, and Software & Service.                                        
By Technology: Quantitative and Digital
By Application: Clinical, Research, Forensic and Other.
By End User: Hospitals & Diagnostic Centers, Research Laboratories and Academic Institutes, Pharmaceutical and Biotechnology Companies, Clinical Research Organizations, Forensic Laboratories and Others.
By Geography: North America (U.S, Canada, Mexico), Europe (Germany, UK, France, Italy, Spain, Russia and Others), Asia-Pacific (China, Japan India, South Korea, Australia and Others), South America (Brazil, Argentina and others) and Rest of the World (Middle East and Africa).

Key Takeaways

  • Geographically, the North America region held 38.4% of the total market share in 2020 owing to the increased adoption of advanced qPCR and dPCR products, robust infrastructure and expanding the use of PCR techniques in clinical diagnostics and forensics.
  • Increasing Prevalence of Chronic infectious and Genetic Diseases are the major driving force for the Digital PCR and Real-time PCR Market during the forecast period 2021-2026.
  • Detailed analysis on the Strength, Weakness and Opportunities of the prominent players operating in the Digital PCR and Real-time PCR Market will be provided in the research report.

Digital PCR and Real-time PCR Market - By Geography, 2020.

Digital PCR and Real-time PCR Market

For more details on this report - Request for Sample

Digital PCR and Real-time PCR Market Segment Analysis- By Application

By Application, the Digital PCR and Real-time PCR Market is classified into Clinical, Research, Forensic and Other. The clinical applications segment accounted for the largest share of the market and is predicted to expand at a high CAGR of 12.7% over the forecast period 2021-2026, owing to increased device sensitivity, greater precision, and absolute quantification of target nucleic acid molecule, the expanding adoption of dPCR among hospitals and diagnostic centers, and the growing global prevalence of Covid-19, cancer, and AIDS are all driving growth in this market sector.

Digital PCR and Real-time PCR Market Segment Analysis - By End User

Based on End User, the global market is segmented as hospitals & diagnostic centers, research laboratories and academic institutes, pharmaceutical and biotechnology companies, clinical research organizations, forensic laboratories and others. The hospital and diagnostic center segment accounted for a major share of Digital PCR and Real-time PCR market in 2020. This is due to the growing market availability of qPCR reagents in clinical diagnostic applications; ongoing expansion of healthcare infrastructure across emerging countries, high prevalence and incidence of target diseases such as Covid-19, cancer, HIV-AIDS, malaria, and tuberculosis and growing awareness among end users about the benefits of qPCR in rapid and effective disease diagnosis.

However, research laboratories and academic institutes are expected to grow at a faster CAGR of 11.7% owing to the rapid advancement in the field of medical biotechnology, and extensive utilization of qPCR and dPCR systems in stem cell research, genetic disease research, and oncology research, among other uses. which is further poised to increase the Digital PCR and Real-time PCR Market rate during the forecast period 2021-2026.

Digital PCR and Real-time PCR Market Segment Analysis - By Geography

Based on geography, North America dominated the Digital PCR and Real-time PCR Market with a region share of 38.4% in 2020 followed by Europe and APAC. Increased adoption of innovative and novel genomic analysis products such as advanced qPCR and dPCR products, robust infrastructure, increasing use of PCR techniques in clinical diagnostics and forensics application, and early commercialization of qPCR/dPCR products are the factors predicted to drive the North America market. Additionally, the presence of large number of Digital PCR and Real-time PCR device manufacturing company that invest heavily in the research and development of technologically advanced devices is further predicted to drive the market growth in the region.

However, Asia Pacific is set to be the fastest growing region owing the increase in the patient pool due to the increased frequency of chronic and infectious diseases, as well as increasing patient awareness about early identification of these diseases, thereby enhancing the demand for PCR products and resulting in market growth.

Digital PCR and Real-time PCR Market Drivers

Increasing Prevalence of Chronic infectious and Genetic Diseases.

The increased use of Digital PCR and Real-time PCR is primarily due to the increasing prevalence of chronic infectious diseases. The use of genomic analysis tools in the diagnosis of major infectious diseases such as Covid-19, HIV, TB, malaria, and hepatitis and genetic abnormalities has increased substantially over the last decade such as cancer. Increase in the global prevalence of target diseases, together with the demonstrated usefulness of qPCR and dPCR analysis in the diagnosis and estimation of disease-causing bacteria, is set to drive up the use of clinical diagnostic tests such as qPCR and dPCR analysis, thereby supporting the market growth.

Digital PCR and Real-time PCR Market Challenge

Unregulated guideline and high Cost of the Product

The use of qPCR and dPCR techniques are currently unregulated over the world, end users are hesitant to employ them in genetic analysis and illness detection. This is mostly due to a lack of uniformity in the methods for conducting qPCR/dPCR experiments in order to acquire high-quality findings in a timely way is the major factor preventing product acceptance. Moreover, the high cost of the procedure and unavailability of the skilled workforce are also limiting the adoption of these devices.

Digital PCR and Real-time PCR Market Landscape:

Product launches, mergers and acquisitions, joint ventures, and geographical expansions are key strategies adopted by players in the Digital PCR and Real-time PCR Market. Key companies of this market are Thermo Fisher Scientific, Bio-Rad Laboratories Inc., F. Hoffmann-La Roche, Ltd., Abbob tt Laboratories, Agilent Technologies, Analytik Jena AG, Becton Dikinson and Company, bioMérieux SA, Danaher Corporation, Eppendorf, Fluidigm Corporation, Merck KGaA, QIAGEN N.V., Takara Bio, Meridian Bioscience, Promega Corporation, Enzo Life Sciences, Inc., Bioneer, ELITech Group and others.

Developments:

  • In September 2020, BioMérieux S.A recieved The CE Mark clearance for SARS-CoV-2 R-GENE tests that incorporate saliva specimens.
  • In May 2020, Bio-Rad received FDA emergency use authorization for the Droplet Digital PCR SARS-CoV-2 Test Kit.

Relevant reports

Report Code: HCR 99177

Report Code: HCR 68052

For more Lifesciences and Healthcare related reports, please click here
1. Digital PCR And Real-time PCR Market Overview
    1.1 Definitions and Scope
2. Digital PCR And Real-time PCR Market Executive Summary
    2.1 Market Revenue, Market Size and Key Trends
    2.2 Key trends By Product and Service
    2.3 Key trends By Application
    2.4 Key trends By End User
    2.5 Key trends By Geography
3. Digital PCR And Real-time PCR Market Landscape
    3.1 Product Benchmarking- Key Companies
    3.2 Financial Analysis- Key Companies
    3.3 Patent Analysis
    3.4 Pricing Analysis–Average Pricing
4. Digital PCR And Real-time PCR Market- Startup companies Scenario Premium Premium
    4.1 Key startup company Analysis by
        4.1.1 Investment
        4.1.2 Revenue
        4.1.3 Application Analysis
        4.1.4 Venture Capital and Funding Scenario
5. Digital PCR And Real-time PCR Market- Industry Market Entry Scenario Premium Premium
    5.1 Regulatory Framework Overview
    5.2 New Business and Ease of Doing business index
    5.3 Case Studies of successful ventures
6. Digital PCR And Real-time PCR Market Forces
    6.1 Market Drivers
    6.2 Market Constraints and Challenges
    6.3 Porters Five Force Model
        6.3.1 Bargaining Power of Suppliers
        6.3.2 Bargaining Powers of Customers
        6.3.3 Threat of New Entrants
        6.3.4 Rivalry Among Existing Players
        6.3.5 Threat of Substitutes
7. Digital PCR And Real-time PCR Market Strategic Analysis
    7.1 Value Chain Analysis
    7.2 Opportunities Analysis
    7.3 Market Life Cycle
8. Digital PCR And Real-time PCR Market– By Product and Service
    8.1 Instruments
    8.2 Reagents & Consumables
    8.3 Software & Services
9. Digital PCR And Real-time PCR Market– By Technology
    9.1 Quantitative
    9.2 Digital
10. Digital PCR And Real-time PCR Market– By Application
    10.1 Clinical
        10.1.1 Pathogen Testing
        10.1.2 Blood Screening
        10.1.3 Oncology Testing
        10.1.4 Others
    10.2 Research
    10.3 Forensic
    10.4 Other
11. Digital PCR And Real-time PCR Market– By End User
    11.1 Hospitals and Diagnostic Centers
    11.2 Research Laboratories and Academic Institutes
    11.3 Pharmaceutical and Biotechnology Companies
    11.4 Clinical Research Organizations
    11.5 Forensic Laboratories
    11.6 Other
12. Digital PCR And Real-time PCR Market- By Geography
    12.1 North America
        12.1.1 U.S
        12.1.2 Canada
        12.1.3 Mexico
    12.2 Europe
        12.2.1 U.K
        12.2.2 Germany
        12.2.3 France
        12.2.4 Spain
        12.2.5 Italy
        12.2.6 Russia
        12.2.7 Rest of Europe
    12.3 Asia Pacific
        12.3.1 India
        12.3.2 China
        12.3.3 Japan
        12.3.4 Australia
        12.3.5 South Korea
        12.3.6 Rest of Asia pacific
    12.4 South America
        12.4.1 Brazil
        12.4.2 Argentina
        12.4.3 Rest of South America
    12.5 Rest of the World
        12.5.1 Middle East
        12.5.2 Africa
13. Digital PCR And Real-time PCR Market Entropy
14. Digital PCR And Real-time PCR Market- Industry / Segment Competition landscape Premium Premium
    14.1 Market Share Analysis
        14.1.1 Market Share by Country- Key companies
        14.1.2 Market Share by Region- Key companies
        14.1.3 Market Share at Global Level- Key companies
        14.1.4 Best Practices for Companies
15. Digital PCR And Real-time PCR Market- Key Company List by Country Premium Premium
16. Digital PCR And Real-time PCR Market Company Analysis (Company Revenue, Products, M&A, Developments)
    16.1 Company 1
    16.2 Company 2
    16.3 Company 3
    16.4 Company 4
    16.5 Company 5
    16.6 Company 6
    16.7 Company 7
    16.8 Company 8
    16.9 Company 9
    16.10 Company 10
   "*Financials for private companies would be provided on a best efforts basis”.    

List of Tables

1 US Digital PCR And Real-time PCR Market Size 2018
2 Canada Digital PCR And Real-time PCR Market Share 2018
3 Brazil Digital PCR And Real-time PCR Market Outlook 2019 - 2023
4 Mexico Digital PCR And Real-time PCR Market Research 2018
5 Germany Digital PCR And Real-time PCR Market Trends 2019 - 2023 
6 France Digital PCR And Real-time PCR Market Growth 2019 - 2023 
7 UK Digital PCR And Real-time PCR Market Demand 2019 - 2023 
8 Italy Digital PCR And Real-time PCR Market Segmentation 2018
9 Russia Digital PCR And Real-time PCR Market Analysis 2019 - 2023
10 China Digital PCR And Real-time PCR Market Revenue 2019 - 2023
11 Japan Digital PCR And Real-time PCR Market Volume 2019 - 2023
12 South Korea Digital PCR And Real-time PCR Market Potential 2019 - 2023
13 India Digital PCR And Real-time PCR Market Leaders 2018
14 Saudi Arabia Digital PCR And Real-time PCR Market Forecast 2019 - 2023 
15 Kuwait Digital PCR And Real-time PCR Market Value 2018

List of Figures

For complete list of 60+ tables and 60+ figures follow the Link